CLINICAL_TRIALS
trial_result
· 2022-04-27
Clinical Trial Update: Urea Cream Prevention for Capecitabine Associated Hand Foot Syndrome [Phase 2, Phase 3]
Summary
Phase 2/Phase 3 trial update evaluating urea cream for prevention of capecitabine-associated hand-foot syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mahidol University | Conditions: Hand-Foot Syndrome | Phase 2, Phase 3 | Status: UNKNOWN